市場調查報告書
商品編碼
925286

解凍系統市場 - 成長,趨勢,預測(2020∼2025)

Thawing System Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球解凍系統市場,從2020年∼2025年以12.8%的年複合成長率擴大。多樣的應用中解凍設備的使用增加,各種疾病治療用的解凍細胞的需求增加,擴大解凍系統的市場。 生物科技及製藥公司的研究開發計劃的投資增加,推動市場成長,血庫的增加和血漿療法的優點的認識,促進市場成長。但,自動設備的高成本是市場成長的阻礙因素。

本報告提供解凍系統的世界市場調查,市場概要,各類型、終端用戶、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊 。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 成長要素
    • 生物醫藥品產業上解凍系統的使用增加
    • 解凍細胞的需求增加
  • 阻礙因素
    • 自動化的高成本
  • 波特的五力分析

第5章 市場區隔

  • 各設備類型
    • 手動設備
    • 自動化設備
  • 各樣品
    • 血液
    • 卵子
    • 其他
  • 各終端用戶
    • 醫院、診斷研究所
    • 血液銀行、輸血中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Sartorius AG
    • BioCision.
    • CytoTherm
    • Boekel Scientific
    • Helmer Scientific Inc.
    • Cardinal Health
    • Barkey GmbH & Co. KG
    • Helmer Scientific
    • Sarstedt

第7章 市場機會及未來趨勢

目錄
Product Code: 67812

The thawing system market studied was projected to grow with a CAGR of nearly 12.8% over the forecast period. The major factors attributing to the growth of the market are increasing usage of thawing devices in various applications and increasing demand for thawed cells for treatments of different diseases. Furthermore, the growing investments in research and development programs by the biotechnology and pharmaceutical companies are boosting the market growth. The rising number of blood banks and awareness of advantages of plasma therapy are few other factors driving the growth of the market. However, the high cost of automatic devices is the major drawback of market growth.

Key Market Trends

The blood sample segment is projected to dominate the thawing system market

  • Since fresh blood and its components can be stored only for a certain period of time, freezing blood products can help enable a steady supply of life-saving transfusions for patients, even in rural areas and other places which are hard to reach. In life sciences research and clinical trials, blood samples are taken from persons taking part in research or trials for evaluations such as measuring metabolites or biomarkers present in the blood of the individual. Generally, relevant blood samples are frozen and stored in a central laboratory for additional retrospective studies and future analysis. Since blood serum is the preferred sample for various clinical assays, many samples are also stored in this way
  • The factors pushing the segment growth are the increasing prevalence of hematological diseases and increasing awareness of advantages of plasma therapy. As per the data published by the American Society of Hematology 900,000 people in the United States develop blood clots yearly, and they are accountable for approximately 100,000 casualties each year.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall thawing system market, throughout the forecast period. The market growth is due to the factors such as enhancements in the blood bank and biobank infrastructure, increasing research activities in regenerative medicine as well as cell and gene therapy. Furthermore, growing interest in customized medicine and biomarker discovery, a growing number of biotechnology and pharmaceutical companies, and increasing government funding are the few factors which are driving the market in this region.

Competitive Landscape

The thawing system market is moderately competitive and consists of several major players. Some of the companies which are currently domianting the market are Sartorius AG, BioCision., CytoTherm, Boekel Scientific, Helmer Scientific Inc., Cardinal Health, Barkey GmbH & Co. KG, Helmer Scientific, Sarstedt.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Usage of Thawing System in the Biopharmaceuticals Industry
    • 4.2.2 Increasing Demand for Thawed Cells
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Automation
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Device Type
    • 5.1.1 Manual Devices
    • 5.1.2 Automated Devices
  • 5.2 By Sample
    • 5.2.1 Blood
    • 5.2.2 Embryos
    • 5.2.3 Ovum
    • 5.2.4 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals & Diagnostic Laboratories
    • 5.3.2 Blood Banks & Transfusion Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Sartorius AG
    • 6.1.2 BioCision.
    • 6.1.3 CytoTherm
    • 6.1.4 Boekel Scientific
    • 6.1.5 Helmer Scientific Inc.
    • 6.1.6 Cardinal Health
    • 6.1.7 Barkey GmbH & Co. KG
    • 6.1.8 Helmer Scientific
    • 6.1.9 Sarstedt

7 MARKET OPPORTUNITIES AND FUTURE TRENDS